Skip to content
Tata Chemicals logo

Tata Chemicals

TATACHEM NSE
₹603.10 −6.55 (−1.07%)
P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹603.10 −269.75 −30.9% 1Y
Start ₹872.85

Key Fundamentals

SmallcapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
3.42%
Debt to Equity
0.38
EPS (TTM)
−₹84.97
Book Value
₹832.38
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
0.72
ROE
1.27%
Dividend Yield
1.80%
EBITDA
₹2,121 Cr
52W High
₹894.00
52W Low
₹570.05
Day Range
₹601.15 – ₹613.25
Volume
10,32,369

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

31 Poor

Data confidence 93/100

Category scores

Quality
21
Poor
Returns, margins, earnings quality 22% weight
Valuation
58
Good
Cheap vs sector & own history 24% weight
Growth
21
Poor
Sales & profit trajectory 9% weight
Financial Health
27
Poor
Solvency, leverage, coverage 9% weight
Momentum
20
Poor
Trend strength, vol-adjusted 12% weight
Ownership
20
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Stock is trading at 0.77 times its book value
  • Company has been maintaining a healthy dividend payout of 82.4%

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.41% over past five years.
  • Company has a low return on equity of 1.59% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1072
OscillatorsNeutral171
Moving AveragesStrong Bearish901

Key readings

RSI (14)
45.23
Neutral
MACD (12,26,9)
−9.35
Bullish
SMA (50)
631.61
Bearish
SMA (200)
688.37
Bearish

As of

Analyst Rating

Based on 7 analysts
SELL57%

1 of 7 analysts rate Buy, 2 Hold, 4 Sell.

As of

BUY
1
14%
HOLD
2
29%
SELL
4
57%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y−0.20%
5Y+7.41%
3Y−4.58%
1Y−2.04%
TTM+2.04%

Net profit

Net profit growth by window
10YTurned to loss
5YTurned to loss
3YTurned to loss
1YTurned to loss
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
10Y−5.90%
5Y−9.03%
3Y−24.69%
1Y−27.94%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−1.71 pp
5Y−2.38 pp
3Y−10.37 pp
1Y−0.74 pp
TTM−2.49 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹10,346 Cr
Mar 2018₹10,270 Cr
Mar 2019₹10,337 Cr
Mar 2020₹10,357 Cr
Mar 2021₹10,200 Cr
Mar 2022₹12,622 Cr
Mar 2023₹16,789 Cr
Mar 2024₹15,421 Cr
Mar 2025₹14,887 Cr
Mar 2026₹14,584 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1,234 Cr
Mar 2018₹2,702 Cr
Mar 2019₹1,387 Cr
Mar 2020₹7,228 Cr
Mar 2021₹436 Cr
Mar 2022₹1,405 Cr
Mar 2023₹2,434 Cr
Mar 2024₹435 Cr
Mar 2025₹387 Cr
Mar 2026−₹1,715 Cr

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹320 Cr −46.1% vs Jun 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 30 Oct 2026
AI opinion · based on fundamentals
Risk high

Tata Chemicals Ltd trades at ₹595.6 as of 2026-10-30 with a market cap of ₹15,173 crore, reflecting a price-to-book ratio of 0.72 and a negative trailing twelve-month EPS of -₹84.97. The company faces significant profitability headwinds with a TTM profit decline of -193% and negative ROE of -7.73%, though it maintains a moderate balance sheet with a debt-to-equity ratio of 0.38 and offers a dividend yield of 1.82%.

Bull Case 6
  • Debt-to-equity ratio stands at a manageable 0.38, indicating the balance sheet is not overleveraged despite current profitability challenges
  • Dividend yield of 1.82% with a historical payout ratio of 82.4% signals the company's commitment to returning cash to shareholders even during a difficult earnings cycle
  • 10-year stock price CAGR of 10% demonstrates that the company has created value for long-term holders across prior business cycles
  • 5-year compounded sales growth of 7% and TTM sales growth of 2% show the top line remains positive even as profitability has come under pressure
  • 5-year compounded profit growth of 3% indicates the company was able to deliver modest earnings expansion over a medium-term window before the recent sharp deterioration
  • 10-year average ROE of 10% suggests the underlying business has historically generated reasonable returns on equity, and the current -7.73% may reflect a cyclical trough rather than a permanent impairment
Bear Case 8
  • TTM EPS is deeply negative at -₹84.97 and TTM profit has contracted -193%, pointing to severe earnings deterioration that may take multiple quarters to reverse
  • ROE has collapsed from a 10-year average of 10% to -7.73% currently, with the last-year ROE at just 1% and 3-year average at only 2%, reflecting a persistent downward trend in capital efficiency
  • ROCE stands at -2.69%, meaning the company is currently destroying value on its total capital employed
  • The stock has fallen roughly 34% from its 52-week high of ₹909 to the current ₹595.6, and the 1-year stock CAGR of -30% reflects sustained negative momentum
  • 10-year compounded sales growth of 0% and 3-year compounded sales growth of -5% highlight a stagnant to shrinking revenue base over extended periods
  • 3-year compounded profit decline of -51% indicates the earnings erosion is not merely a one-quarter anomaly but a multi-year trend
  • Low interest coverage ratio suggests operating profits are insufficient to comfortably service debt obligations, adding financial risk if conditions worsen
  • 5-year stock CAGR of -8% and 3-year CAGR of -14% show the company has consistently underperformed for shareholders over medium-term horizons

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

9h ago

TL;DR: Tata Chemicals is navigating multiple legal fronts but managing them effectively. The ₹908 crore arbitration win is a clear positive, materially reducing contingent liability. The Kenya subsidiary dispute and Mithapur land case remain unresolved but carry interim protections, with Kenya contributing only ~6% of EBITDA. The legal trajectory appears to be stabilising, though the Kenya situation warrants monitoring given declining subsidiary profitability.

Positives 1
  • ₹908 Cr claim largely dismissed Oct 16

    Tata Chemicals won a final arbitration award rejecting Allied Silica's ₹908 crore claim. The tribunal directed only a minor ₹1 crore payment plus interest, significantly reducing legal liability.

Neutral 2
  • Kenya subsidiary jurisdiction dispute Oct 24

    Kenya's High Court ruled on Oct 23 that it lacks jurisdiction over the TCML dispute, while a high-level committee reviews matters raised by Kenya's mining ministry. TCML's revenue fell to ₹586 crore in FY26 from ₹612 crore in FY25, EBITDA dropped to ₹101 crore from ₹142 crore, and PAT declined to ₹48 crore from ₹118 crore, though the unit contributes only ~6% of consolidated EBITDA.

  • SC halts coercive action in Mithapur Oct 6

    The Supreme Court on Oct 5 restrained the Gujarat government from taking coercive action against Tata Chemicals in an environmental damage case at Mithapur, issuing notice and granting interim protection.

Quarterly Results

₹ Cr
TATACHEM quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4,218
3,998
3,730
3,475
3,789
3,999
3,590
3,509
3,719
3,877
3,550
3,438
4,255
Expenses
3,175
3,191
3,188
3,032
3,215
3,381
3,156
3,182
3,070
3,340
3,205
3,164
3,717
Operating Profit
1,043
807
542
443
574
618
434
327
649
537
345
274
538
OPM %
25%
20%
15%
13%
15%
15%
12%
9%
17%
14%
10%
8%
13%
Other Income
67
187
98
−861
116
152
−10
29
138
128
21
−1,760
56
Interest
123
145
132
130
133
145
148
137
147
144
146
153
148
Depreciation
229
234
246
271
273
277
280
293
280
285
293
343
336
PBT
758
615
262
−819
284
348
−4
−74
360
236
−73
−1,982
110
Tax %
23%
20%
26%
3%
33%
23%
425%
−34%
12%
35%
−5%
7%
45%
Net Profit
587
495
194
−841
190
267
−21
−49
316
154
−69
−2,116
60
EPS (₹)
20.88
16.8
6.2
−33.36
5.89
7.61
−2.08
−2.2
9.89
3.02
−3.65
−83.67
−0.67

Profit & Loss

₹ Cr
TATACHEM profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17,204
14,873
10,346
10,270
10,337
10,357
10,200
12,622
16,789
15,421
14,887
14,584
15,120
Expenses
15,305
12,777
8,249
6,926
8,538
8,411
8,693
10,303
12,969
12,574
12,934
12,779
13,426
Operating Profit
1,900
2,096
2,097
3,344
1,799
1,945
1,506
2,319
3,820
2,847
1,953
1,805
1,694
OPM %
11%
14%
20%
33%
17%
19%
15%
18%
23%
18%
13%
12%
11%
Other Income
183
210
293
262
785
6,480
254
472
218
−507
287
−1,473
−1,555
Interest
461
525
297
326
354
342
367
303
406
530
563
590
591
Depreciation
463
526
512
518
568
666
759
806
892
980
1,123
1,201
1,257
PBT
1,159
1,255
1,580
2,763
1,661
7,416
634
1,682
2,740
830
554
−1,459
−1,709
Tax %
30%
20%
22%
2%
17%
3%
31%
16%
11%
46%
30%
18%
—
Net Profit
802
1,006
1,234
2,702
1,387
7,228
436
1,405
2,434
435
387
−1,715
−1,971
EPS (₹)
23.41
30.24
38.98
95.49
45.37
275
10.06
49.36
90.93
10.52
9.22
−74.41
−84.97
Div. Payout %
53%
33%
28%
23%
28%
4%
99%
25%
19%
143%
119%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—

Balance Sheet

₹ Cr
TATACHEM balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
255
255
255
255
255
255
255
255
255
255
255
255
Reserves
5,297
6,600
7,653
10,847
12,086
12,643
14,035
17,998
19,466
21,986
21,339
20,951
Borrowings
8,379
9,090
7,072
6,108
6,130
7,702
6,933
7,025
6,296
5,563
7,072
8,001
Other Liabilities
6,872
8,402
8,607
8,648
8,398
7,073
7,115
8,566
8,923
8,907
9,084
9,791
Total Liabilities
20,802
24,346
23,587
25,858
26,869
27,673
28,337
33,843
34,940
36,711
37,750
38,998
Fixed Assets
11,359
13,431
12,644
12,787
13,551
15,356
15,261
16,044
17,092
17,861
19,600
20,602
CWIP
189
350
333
409
774
835
1,094
1,667
2,410
2,217
1,913
1,038
Investments
443
2,188
2,787
2,840
5,615
4,285
5,816
7,683
7,448
9,739
9,144
9,886
Other Assets
8,811
8,377
7,822
9,822
6,929
7,198
6,167
8,449
7,990
6,894
7,093
7,472
Total Assets
20,802
24,346
23,587
25,858
26,869
27,673
28,337
33,843
34,940
36,711
37,750
38,998

Cash Flow

₹ Cr
TATACHEM cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,274
2,332
3,531
1,870
1,581
1,780
2,037
1,644
2,971
3,016
1,761
1,269
Investing
−663
−463
−985
2,714
−1,927
−2,285
−1,147
−817
−1,149
−605
−1,667
−766
Financing
−1,087
−1,802
−2,341
−2,089
−1,712
−129
−1,456
−755
−2,076
−2,494
29
−670
Net Cash Flow
−477
68
205
2,494
−2,058
−634
−565
72
−254
−83
123
−167
Free Cash Flow
709
1,645
2,888
1,140
502
611
804
379
1,427
1,193
−191
129
CFO/EBITDA
86
129
190
71
115
99
142
82
88
120
102
67

Ratios

TATACHEM financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
73
88
74
46
51
56
50
56
57
45
47
52
Inventory Days
137
119
244
304
315
347
257
317
282
341
324
353
Days Payable
138
99
232
307
269
302
256
338
289
320
318
293
Cash Conversion Cycle
72
107
86
43
97
100
51
35
50
66
53
113
Working Capital Days
−4
31
−4
27
−2
−102
−28
−29
29
−22
−21
−17
ROCE %
11%
11%
10%
16%
9%
36%
4%
8%
12%
8%
4%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tata Chemicals insights

69 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 37.98%
  • Public 25.41%
  • DIIs 19.65%
  • FIIs 11.70%
  • Others 5.23%
  • Government 0.03%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Tata Chemicals

What does Tata Chemicals Ltd do?
Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products
Where is Tata Chemicals Ltd (TATACHEM) listed?
Tata Chemicals Ltd trades as TATACHEM on the NSE and under code 500770 on the BSE.
Which sector does Tata Chemicals Ltd belong to?
Tata Chemicals Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the 52-week high and low of Tata Chemicals Ltd?
Over the last 52 weeks Tata Chemicals Ltd has traded between ₹570.05 and ₹894 as of 4 Nov 2026.
Does Tata Chemicals Ltd pay dividends?
Tata Chemicals Ltd has a dividend yield of 1.80%.
What is the Return on Equity (ROE) of Tata Chemicals Ltd?
Tata Chemicals Ltd reported a return on equity of 1.27%. Its debt-to-equity ratio is 0.38.

Company Information

Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products

Website tatachemicals.com
CEO Mr. Ramakrishnan Mukundan B.E.(Elec), MBA
Employees 4,789
Listed 1 Apr 1999
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TATACHEM.md for Tata Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month